ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2018

Should decisions on adding adjuvant chemotherapy in early-stage ER-positive breast cancer be based on gene expression testing or clinicopathologic factors or both?

D B GeffenPubMed ↗Publisher ↗

No numbers read from the abstract.